GLY510

GLY510 is a novel synthetic glycoprotein designed for the treatment of anaemia.

Monoclonal Antibodies

GlycoForm is focusing its efforts on the development of partnerships and competencies for the clinical exploitation of monoclonal antibodies (mAb) or products derived from them.

Glyco-SeS

GlycoForm's Glyco-SeS technology utilises the properties of selenium and sulfur compounds to ligate sugars to proteins through disulfide bonds.